text stringclasses 974
values |
|---|
leukemia breast cancer cell lines growth inhibitory effects reversed leukemia cell lines first show evidence thiaminase therapeutic potential demonstrating activity breast leukemia xenografts primary leukemia xenograft therefore explored metabolic effects thiaminase combination leukemia breast cell lines decreased oxyg... |
instrument variability overall process variability Following normalization total protein assay log transformation minimum observed values compound two sample tests used identify differed significantly experimental groups entire data sets RS MCF cells statistical results included data tables Table analysis Cells treated... |
chain amino acid enzymes reactions produce substrates total phosphorylated subunit E E E respectively RS leukemia cells treated thiaminase C vs C vs R comparisons indicates p indicates p assay RS MCF cells treated increasing concentrations thiaminase control conditions medium contains also affected amino acids RS leuke... |
results suggest critical role P breast cancer progression identify P potential therapeutic target biomarker breast cancer progression Tumor microenvironment Breast cancer deposition Cancer progression Cell proliferation Background matrix important component tumor microenvironment plays critical roles cancer development... |
established risk factor susceptibility lung cancer However people lung cancer smokers Lung cancer non smokers induced second hand smoke air present data showed significant difference year smoking status NSCLC cases controls suggested important role environmental factors development NSCLC could induce chronic inflammati... |
year disease free survival rate significant statistical differences year disease free survival rate p open thoracotomy Conclusions VATS approach safe feasible treatment terms survival rate metastatic lung cancer compared thoracotomy year disease free survival rate VATS group inferior open thoracotomy VATS approach coul... |
b c V f b C b C b Chen L e f H MD g J MD h J MD R MD j MD g B MD k F MD l B MD b Medical Center Surgery Department Medicine University Medical Center Medicine Public Health University Medical Center Epidemiology University Medical Center Sciences University Medical Center Statistics Clinic Surgery University NC Surgery... |
appropriate skin entry site successful placement needle location location basal portion around line needle tip mm depth avoid pulmonary vessels placed needle cm length lung parenchyma appropriate skin entry site parameters CT used study tube tube current thickness mm thickness speed connected mL needle hub confirm bloo... |
CT guided percutaneous injection material study supported grant Seoul National University College Medicine Research potential interest commercial involvement G H preoperative computed tomography guided localization video assisted thoracoscopic surgery pulmonary metastatic pulmonary nodules Ann Thorac Surg Chen Zhou J Z... |
important environmental genetic factors lung adenocarcinoma cooking oil smoke passive smoking exposures implicated possible risk factors among Chinese women mainly based Chinese people traditional diet lifestyle social environment designed study evaluate association genetic variant environmental risk factors lung adeno... |
emerging differences epidemiology biology therapy Chest lung cancer risk men women examination evidence J Natl Cancer Study risk factors lung cancer non smoking women et al Chinese food cooking lung cancer women J et al functional single nucleotide polymorphism promoter ATM associated Identification cooking oil Res stu... |
test p value PFS OS results EGFR PCR test positive patients differ significantly obtained patients enrolled EURTAC trial suggests EGFR PCR test positive patients representative EURTAC enrolled patients cases EGFR PCR test result mutation detected LDT two cases resolved LDT MPP three cases resolved EGFR PCR test one sam... |
Medicine University California San CA USA Department Health Sciences University USA Department Health Sciences University California CA USA Division Public Health Sciences Cancer Research Center USA School Public Health University BC V Z Department Health University DC USA Hospital Cancer Center Shanghai China E edu Co... |
R G J J C intervention decrease related infections ICU N Engl J Med CM RA RJ NA JM randomized trial peer review UK National Chronic Pulmonary Disease Outcomes Project three year evaluation J Clin C MD J N L E K G ML J J E B Group Lung cancer survival stage diagnosis UK population based study J Health atlas shows large ... |
physical role cognitive social three symptom fatigue pain nausea vomiting global health quality life scale array single item symptom measures role functioning global health physical functioning scale internal consistency varied except cognitive functioning scale varying reliability varied lung cancer questionnaire modu... |
end stage disease J b e f PR symptoms lung cancer patients Health Kim PR MR symptoms people lung cancer effects social support caregiving burden N family caregivers lung cancer patients examination practical challenges Care Cancer health mental health life changes among family caregivers patients lung cancer Oncol U C ... |
following treatment scFvMTBHsp control proteins normal saline mouse model papillary ovarian cancer immune FVB NJ mice scFvMTBHsp prolonged free survival time compared saline n per group representative two independent experiments median survival Med days vs days mixture MTBHsp plus P scFv Med days scFvMTBHsp also prolon... |
cross presentation studies harvested animal injections obtained FVB mice via vein lysis using buffer R systems Small peritoneal membrane taken mice enzyme free cell buffer obtain mouse peritoneal cells test whether scFvMTBHsp MTBHsp binds MSLN expressing tumor cells non cancerous cells incubated BR FVB ovarian tumor ce... |
Huang Q K RA vivo cytotoxic lymphocyte heat shock protein fusion proteins maps domain CD cell independent Journal experimental medicine LA JM MM CS BR CA adjuvant effects heat shock protein result rapid prolonged activation antigen specific CD cells vivo J Cancer immunotherapy dendritic cells j F N CD cell dendritic ce... |
resistant NSCLC tumor models AZD BEZ lung tumor tissues assessed evaluating Ki expression using immunohistochemical analyses observed active cell proliferation NCI H tumor model proliferation index Figure AZD BEZ slightly decreased percentage Ki positive tumor tissues proliferation respectively Figure treatment AZD BEZ... |
V V Mean dose Gy dose Gy dose Gy Index Index plans used four five non compared nine ten photon plans Figure average number monitor units per field range range would average beam time per field versus photon proton plans respectively differences monitor units beam time statistically significant P Table journal pone g Fi... |
trial achieved primary feasibility objective treatment assignment within patients successfully determined protein levels patients eligible patients achieve assignment treatment versus observation within day time interval surgical resection time interval surgery assignment ranged days days patients patients specimens re... |
results show adverse effect acute lung injury human lungs material potentially pathologic diagnosis target lesion due acute inflammation knowledge study indicated lipiodol methylene blue histopathologic diagnosis target lesions human lungs small amount material injection human lungs might create significant change unde... |
therapeutic target Recently indicated CR G polymorphism plays critical role genetic susceptibility cancer population However association genetic variants CR risk lung cancer remains lung cancer common cancer terms incidence mortality NSCLC common subtype lung cancer less aggressive SCLC Although cigarette smoking risk ... |
controls suggested important role environmental factors development NSCLC could induce chronic inflammation lung microenvironment contributing pulmonary carcinogenesis smokers also data regarding inflammation lung cancer CR important molecule implicated immunity inflammation could protect host invasion exogenous derive... |
rs C rs C rs G rs G rs C rs C rs G rs C rs C Statistical analysis used test examine differences distributions demographic characteristics genotype frequencies cases controls NSCLC risk associated CR SNPs estimated odds ratios confidence intervals CI computed logistic regression model adjusted age gender smoking status ... |
Nat Genet ng RJ JD V P N J P E V L V Chen C G G J Liu G F MB K L J susceptibility locus lung cancer maps receptor subunit genes q Nature nature Wang P E Wu X J Dong Q X Chen MR CI RS p p variants influence lung cancer risk Nat Genet ng JD RJ V P G N J P E V L V J F F MB L Chen C G MM Lung cancer susceptibility locus p ... |
studies sensitivity analysis performed compare year survival rate year disease free survival rate VATS open thoracotomy bias plot used explore bias plot trial size treatment effect used assess risk bias Results studies retrospective cohort studies met criteria included meta analysis total patients included six studies ... |
First cancer deaths included analysis year overall survival might account VATS comparable overall survival rate inferior disease free survival rate patients VATS group might lesions likely relapse lung leading inferior year disease free survival rate Third included studies early period VATS development technology compl... |
cases International Lung J Thorac Surg site metastasis complication thoracoscopic Eur J Surg Oncol site laparoscopic thoracoscopic procedures malignancy J Clin Oncol Pulmonary common practice based weak evidence Ann R Surg Engl et al Comparison median thoracotomy resection pulmonary metastases patients adult soft tissu... |
accuracy calculated entire cohort differences based preoperative size site examined Results FDG PET results available participants enrolled sites Lung cancer prevalence FDG PET sensitivity CI specificity CI Positive negative predictive values respectively improved lesion size false positive scans negative scans occurre... |
Diagnostic value KLK NSCLC ROC curve analysis carried assess value KLK NSCLC area ROC curve confidence interval CI cutoff point ng ml defined normal value based mean value plus two standard deviation obtained healthy controls serum KLK sensitivity specificity accuracy positive predictive value negative predictive value... |
apoptosis assayed cells blocking pathway shRNA knockdown small molecule inhibitors mice used determine vivo efficacy inhibitor Results cohorts activation signaling significantly associated classical subtype cell lines genetic knockdown produced minor effects cell survival knockdown significantly reduced proliferation i... |
estimate locations dispersion excellent localized staining Fig maximum diameter staining extent lung surface measured calculated compared scores extent staining two materials findings radio opacity MLM evaluated using point scoring detectable radio opacity minimally increased opacity acceptable low density increased op... |
lead large addition reported dispersion methylene blue throughout entire pleural surface intraoperative identification failure due severe failure rate reported use methylene blue results similar study indicate staining lung surface methylene blue study found dispersion methylene blue MLM lung parenchyma significantly s... |
pain material related could evaluate histopathologic changes effect underlying lung disease lung parenchyma experimental normal Finally evaluate successful localization true target lesion lung parenchyma criteria appropriate staining radio opacity clinical studies might provide MLM useful percutaneous injection materia... |
Chang National Health Research Taiwan E edu Competing authors competing interests exist designed experiments experiments data reagents materials analysis tools paper informed consent subjects Zhou e et al open access distributed terms Creative Commons Attribution License permits unrestricted use distribution reproducti... |
ages cases controls mean almost identical respectively cases female non smoking lung cancer patients statistically significant difference found cases controls terms age P P included non small cell lung cancer NSCLC patients small cell carcinoma patients NSCLC cases adenocarcinomas squamous cell carcinomas tumors variet... |
distribution demographic variables exposed group non exposed group b used compare frequency distribution demographic variables smoke exposure family history cancer passive smoking exposed group non exposed group several limitations current study First hospital based studies likely include controls non malignant lung di... |
mixed cohorts concluded similar results EURTAC trial randomized phase trial assess safety efficacy erlotinib compared standard platinum based chemotherapy first line treatment patient population advanced EGFR mutation detected NSCLC largely population European patients treated patients experienced significant improveme... |
treatment arms months erlotinib arm CI months chemotherapy arm CI log rank test p value PFS OS results EGFR PCR test positive patients differ significantly obtained patients enrolled EURTAC trial suggests EGFR PCR test positive patients representative EURTAC enrolled patients cases EGFR PCR test result mutation detecte... |
sensitivity samples containing less mutant alleles compared agreement valid results EGFR PCR test Sanger sequencing n discordant cases confirmed MPP nine cases resulted mutation detected status EGFR PCR test would make patients eligible anti EGFR therapy sensitivity Sanger sequencing thus relatively low compared EGFR P... |
require ethical review Results One hundred trusts participate participate study one trusts data sufficient quality allow Two trusts provided joint multidisciplinary team allowing pairs multidisciplinary teams created One pair act pilot excluded analysis remaining pairs pairs trusts randomised intervention group remaini... |
participation survey treated confidence take part survey affect care receive NHS way name address questionnaire information required information give questionnaire shared way allows identified complete survey long take questionnaire short take min complete every question questionnaire even every question first language... |
patients lung cancer partners Methods parallel group randomized controlled trial conducted compare MBSR Lung cancer patients received still treatment partners recruited take place baseline post intervention three month follow primary outcome psychological distress e anxiety symptoms outcomes quality life patients careg... |
work absence study period pt Mindfulness adherence study period pt pr Baseline measurement intervention measurement month follow measurement pt Patient pr State Hospital Scale C Quality Life Cancer LC Quality Life Lung Cancer Care SE Assessment Care Model Scale Mindfulness Scale Response Scale Scale stratified accordin... |
lung cancer patients partners trial offer valuable information whether MBSR one available care contributes psychological distress MBSR Mindfulness based stress reduction controlled trial University Medical Centre Mindfulness based cognitive therapy mental state examination Hospital anxiety depression scale C Quality li... |
cancer mesothelioma cells heat shock protein Hsp potent immune activator stimulates monocytes DCs enhances DC aggregation maturation improves cross cells mediated DCs Methods fusion protein MSLN surface tumor cells measured flow cytometry fluorescence microscopy therapeutic efficacy fusion protein evaluated mouse model... |
prolonged free overall survival time compared saline MTBHsp plus P scFv treated mice Figure B B Kaplan survival curves tumor bearing mice following treatment scFvMTBHsp control proteins normal saline mouse model papillary ovarian cancer immune FVB NJ mice scFvMTBHsp prolonged free survival time compared saline n per gr... |
response scFvMTBHsp treatment mediated tumor specific CD cells scFvMTBHsp stimulates maturation murine bone marrow derived dendritic cells order investigate immunological mechanisms involved scFvMTBHsp enhanced anti tumor immune response first examined scFvMTBHsp MTBHsp proteins used study could stimulate maturation bo... |
protein regulates surface expression phenotypic markers DC maturation Interestingly addition CD CD MHC class II molecules expression CD also enhanced indicating possible positive feedback loop involving CD signaling components promoting DC maturation scFvMTBHsp fusion protein also targets tumor cells towards DCs propos... |
h C CO Cells placed collected washed stained following conjugated antibodies anti CD c anti CD anti CD BD anti CD anti MHC class II BD cells analyzed laser BD Biosciences vitro tumor antigen presentation assay BR FVB cells harvested treated C plated well round plate g ml scFvMTBHsp g ml MTBHsp pre incubation C h CD c r... |
mice spleen sections used positive controls CD cells clearly evident sections Scale bar B CD cells quantified randomized fields Click file Additional file Figure Validation vivo depletion CD cells FVB NJ mice injected p g anti CD matched rat IgG described Methods mice vein depletion CD cells examined flow cytometry ana... |
respectively Figure B Figure proliferative effects AZD BEZ NCI H NCI H NCI H gefitinib resistant cell lines Cells treated varying concentrations AZD BEZ B alone h ranged Mean SD n inhibition MEK PI K mTOR synergistic effect gefitinib resistant NSCLC cell lines growth vitro anti proliferative effect combining MEK PI K m... |
early clinical trial evaluation clinical activity single agent rarely observed MEK inhibitors gefitinib resistant NSCLC patients benefit blocking individual pathway largely limited presence feedback loop PI K MEK example inhibition MEK pathway results activation PI K pathway PI K activation mediates resistance MEK inhi... |
concluded combination selective MEK inhibitor PI K mTOR inhibitor effective suppressing growth gefitinib resistant tumors caused EGFR mutation MET amplification KRAS PIK CA mutation findings represent promising strategy treatment gefitinib resistant NSCLC provide strong basis design clinical trials purpose Competing in... |
least dose including range position errors included mm standard scanning proton therapy created based motion tumor volume three using four computed tomography image data dose compared photon proton plans well total time would required treatment radiotherapy delivery time per beam estimated per second proton therapy sca... |
radiation oncology biology et al Radiation Therapy Oncology Group Phase Study Body Radiation Therapy Patients Stage Non Small Cell Lung Cancer International journal radiation oncology biology et al management respiratory motion radiation oncology report Group Medical body radiation therapy clinically challenging cases ... |
scan chest adequate bone marrow liver renal function performance status provide smoking history Patients prior malignancy prior radiation chest significant according good medical practice excluded Patients registered trial within days surgery Tumor specimens retrieved central laboratory analyzed situ tumor levels ERCC ... |
Institute version cancer DFS defined time date enrollment disease recurrence death due cause estimated according Kaplan method Cox regression model fit time surgery enrollment evaluate effect DFS natural log transformation applied raw protein measurement data correlation coefficient used test associations comparison ba... |
months range months months patients cm risk reduction reported tumors measuring cm risk increase reported significant treatment related toxicity reported patients Treatment related deaths occur patients inclusion molecular markers predictive therapeutic efficacy adjuvant decision algorithms would greatly improve clinic... |
among trials cannot account differences study populations eligibility staging criteria data collection analysis spectrum protein levels ERCC RRM significant correlation levels molecules distribution patients gene expression categories current study consistent previous experience However current analysis method biomarke... |
JA patients gland carcinoma without conjunctival invasion JA H BP RC CL carcinoma personal experience cases j JA H BP RC CL carcinoma region review j Wu X Radiation therapy local control eyelid cell carcinoma report two cases review literature Surg Wang JR PC SC PK Chen MS eyelid tumours Taiwan R K beam therapy approac... |
Japan e u ac jp Published University Press Access distributed terms Creative Commons Attribution licence permits non commercial reproduction distribution work medium provided original work altered transformed way work properly cited commercial use contact com family Japanese multiple members developed lung cancer Using... |
mutations restricted tyrosine kinase domain According Cancer accessed genetic mutation reported type cancer Interestingly previous study reported mutation transmembrane domain V E rat gene corresponds V E human homolog induced oncogenic transformation addition vivo experiments showed V E mutation contributed stability ... |
However molecular mechanisms regulate miRNA biogenesis still largely unknown Recent studies shown transcription factors TFs regulate expression protein encoding genes also miRNA biogenesis RNA polymerase II dependent transcription Several TFs including p c HIF directly miRNA promoters regulate miRNA transcription repor... |
growth monitored vivo miRZip contains gene signal miRZip expressing cells lower miRZip control cells Furthermore tumor volume tumor weight also lower miRZip mice miRZip mice N per group E results suggest miR overexpression facilitates lung tumor growth vivo Sp inhibits FOXO expression inducing miR expression investigat... |
migration activities H cells x expressing miRZip miRZip studied Transwell miRZip miRZip stably expressed H cells x l PBS injected lateral vein mice weeks mice number pulmonary tumor nodules calculated fixation lungs h panel number pulmonary metastatic tumor nodules counted panel b E FOXO miR H cells knockdown miRZip re... |
cell proliferation Sp overexpression also cancer cell growth post modifications affect protein function overexpressed proteins might completely processed could affect function Previous studies melanoma hepatocellular carcinoma indicated miR enhanced tumor metastasis However data shown indicated miR knockdown altered ce... |
binding sites mutations site C G F CCA CTC CC R AG site C G F CCA CTC C R G performed PCR using plaque forming unit DNA polymerase Technologies Santa CA immunoprecipitation assay protocol performed described previously Briefly fixed complex mg normal rabbit IgG anti H anti Sp antibodies DNA analyzed PCR primer sequence... |
seeded cm cultured h linear wound cellular created cell using tip cell washed PBS remove incubation CO h area migration light microscope evaluation Transwell migration assay cell migration assay performed using Transwell system mm size filter membrane Cells serum free DMEM wells cell serum free DMEM lower wells DMEM co... |
least subjects per clinic see calculations statistics first patients GP patient give permission contact taking part smoking cessation research possible genetic risk testing fact addressed Figure flow diagram recruitment principal investigator patient would like week smoking cessation clinic would test genetic susceptib... |
Subsequently principal investigator report back clinic patients estimated lung cancer risks session ensure balance control clinic principal investigator also Clinic B sessions see flow eight week clinic month follow clinic smoking cessation status carbon breath test score recorded feedback questionnaire used assess eff... |
related diseases smoking cessation outcomes systematic review meta analysis Control Smith SM U contributing time taken symptoms lung cancer cross study SC SC G L CM online genetic test results among smokers related patients lung cancer pilot study Cancer RP R C Wu L GD GD TE Functional variants antioxidant genes smoker... |
initially present stage IV disease develop distant metastases several months diagnosis still lower five year survival rate Recently range systemic chemotherapy expanded targeted therapy including epidermal growth factor receptor EGFR vascular endothelial growth factor VEGF inhibitor therapies used advanced CRC patients... |
H L using light microscopy improve accuracy results Fig CRC cells considered internal negative controls large vessels considered internal positive controls CD layer medium large vessels considered internal positive controls Samples showing staining internal negative positive controls considered non excluded analysis us... |
including liver lung peritoneal distant lymph nodes metastatic ans examined LVD MVD highest lung previous study KRAS rate also significantly higher matched lung metastases matched metastatic ans underlying mechanism known could primary high LVD MVD produce lung metastases however results indicated LVD MVD center primar... |
J Cancer Tumor angiogenesis invasive breast carcinoma N Engl J Med et al Prognostic significance count colorectal cancer J Clin Oncol et al quantification primary colorectal carcinoma immunohistochemical study Br J Cancer lymphatic vessel density vascular endothelial growth factor C expression early stage squamous cell... |
expression limited number adult lung cells monitored X staining marker K V Four weeks later cells form small clusters However SPC alveolar type II cells able form lesions progressed adenomas adenocarcinomas contrast induction K V expression lung cells infection ps generated regions except proximal junction primarily ma... |
crizotinib response retrieved patient records least partial response treatment defined according Response Evaluation Tumors criteria e least decrease sum target lesions study evaluated classified service evaluation College Research Ethics Committee review sections protease pretreatment steps overnight available ALK dua... |
test IHC result recent studies compare various immunohistochemical assays FISH detection ALK study et al identify FISH positive IHC negative cases explain two cases identifying co mutations oncogenes thereby tumor ALK one insufficient tumor material accurate IHC assessment et al compared assay using antibody FISH speci... |
J Thorac Oncol e e P J New response evaluation criteria solid tumours revised RECIST guideline version Eur J Cancer CI PA ALK lung adenocarcinoma multicenter comparison immunohistochemistry situ hybridization Pathol CM C J C reliable screening tool identification ALK non small cell lung carcinoma antibody dependent J T... |
PFS added cisplatin gemcitabine although OS significantly prolonged secondary end point case et al non squamous histology cisplatin pemetrexed active combination chemotherapy et al thus combinations platinum pemetrexed bevacizumab anti strong interest first line treatment advanced metastatic non squamous NSCLC et al b ... |
patients enrolled participating sites across United States January December patient demographics Median age years male PS evaluation Treatment exposure dose modifications patients received least one dose three study drugs median days treatment range days seven patients completed four cycles combination treatment median... |
baseline antibody end treatment visit patient completed six cycles combination treatment without dose delay reduction grade AEs stable disease one negative baseline positive visit patient experienced minutes start ziv aflibercept infusion day second cycle Study drug patient PK parameters profile different negative pati... |
ziv aflibercept combination standard chemotherapy et al likely development may regimen dependent rather dose schedule dependent posterior syndrome described brain syndrome frequently related hypertension fluid possibly cytotoxic effects immunosuppressive agents vascular et al Risk factors include female sex hypertensio... |
Van E J R H J P van GA V J J R C aflibercept fluorouracil improves survival phase III randomized trial patients metastatic colorectal cancer previously treated oxaliplatin based regimen J Clin Oncol C Zhang L posterior syndrome cancer Oncol Rep KaplanMeier curve PFS N Median PFS months CI B MRI patient diagnosed increa... |
expression p ctn correlated expression E cadherin vimentin lymph node metastasis immunohistochemistry detected expression levels p ctn E cadherin vimentin lung cancer cells Western blot screened cell lines expressing low high levels p ctn E cadherin membrane cytoplasm expression EMT related molecules cell invasion also... |
incubation labeled secondary antibody goat anti mouse labeled goat anti rabbit IgG cat E E San CA USA nuclei propidium iodide microscopy performed using TE microscope NY USA microscopy performed using laser scanning microscope NY USA cell invasion assay cell invasion assays performed according manufacturer instructions... |
End of preview. Expand in Data Studio
Biomedical Text Publication Classification Dataset
Overview
This dataset contains text data for classifying biomedical publications. Each sample is stored in a separate text file, with features space-separated on a single line. The dataset is structured to be compatible with Lumina AI's Random Contrast Learning (RCL) algorithm via the PrismRCL application.
Dataset Structure
The dataset is organized into the following structure:
Cancer_Documents_Classification/ train_data/ category_1/ sample_0.txt sample_1.txt ... category_2/ sample_0.txt sample_1.txt ... test_data/ category_1/ sample_0.txt sample_1.txt ... category_2/ sample_0.txt sample_1.txt ...
Note: All text file names must be unique across all category folders.
Features
- Tabular Data: Each text file contains space-separated values representing the features of a sample.
- Categories: There are multiple categories, each represented by a separate folder based on the type of publication.
Usage (not pre-split; optimal parameters)
Here is an example of how to load the dataset using PrismRCL:
C:\PrismRCL\PrismRCL.exe chisquared rclticks=15 boxdown=0 channelpick=5 data=C:\path\to\Cancer_Documents_Classification_mm testsize=0.1 savemodel=C:\path\to\models\mymodel.classify log=C:\path\to\log_files stopwhendone
Explanation of Command:
C:\PrismRCL\PrismRCL.exe: Path to the PrismRCL executable for classificationchisquared: Specifies Chi-squared as the training evaluation methodrclticks=15: Sets the number of RCL iterations during training to 15boxdown=0: Configuration parameter for training behaviorchannelpick=5: RCL training parameterdata=C:\path\to\Cancer_Documents_Classification_mm: Path to the complete dataset for Cancer Documents Classificationtestsize=0.1: Specifies that 10% of the data should be used for testingsavemodel=C:\path\to\models\mymodel.classify: Path to save the resulting trained modellog=C:\path\to\log_files: Directory path for storing log files of the training processstopwhendone: Instructs PrismRCL to end the session once training is complete
License
This dataset is licensed under the Creative Commons Attribution 4.0 International License. See the LICENSE file for more details.
Original Source
This dataset was originally sourced from the Kaggle Dataset Repository. Please cite the original source if you use this dataset in your research or applications.
Additional Information
The data values have been prepared to ensure compatibility with PrismRCL. No normalization is required as of version 2.4.0. ```
- Downloads last month
- 7